Airdoc Wins 'Asia-Pacific Best Innovation Award in Medical AI' at Boao Forum's 2nd Global Health Expo

6Month1Days6Month4Day, the 2nd Global Health Forum of Boao Forum for Asia (hereinafter referred to as“GHFConference”）and the 2nd Global Health ExpoHeld in Qingdao. AirdocAirdoc(Full Name“Beijing Airdoc Technology Co., Ltd.”) Obtain“2021Best Innovation Award for Medical AI in the Asia-Pacific Region”。

On the morning of June 1, at the 2nd Boao Forum for Asia Global Health Expo held in the International Exhibition Center of China Railway Qingdao World Expo City, Frost & Sullivan (hereinafter referred to as “Sullivan”), a renowned global growth consulting firm and strategic partner of the GHF conference, presented awards to outstanding enterprises from the global health industry. Among them, Airdoc, a Chinese medical AI company, received the “2021 Best Innovation Award for Medical Artificial Intelligence in the Asia-Pacific Region.”

Sullivan Awards Beijing Airdoc Technology Co., Ltd.

“2021 Asia-Pacific Best Innovation Award for AI in Healthcare”

Mr. Zhu Yi, Consulting Director of the Healthcare Division at Frost & Sullivan Greater China, stated that based on comprehensive research and analysis of primary and secondary data on the artificial intelligence (AI) medical imaging market in the Asia-Pacific region, as well as studies and evaluations of relevant companies—including in-depth interviews with leading practitioners and industry experts in the fields of AI medical imaging and AI retinal auxiliary diagnosis—Frost & Sullivan, after detailed comparative analysis, has decided to award Airdoc the “2021 Best Innovation Award for Medical Artificial Intelligence in the Asia-Pacific Region,” thereby recognizing Airdoc’s outstanding achievements in the AI medical imaging and AI retinal auxiliary diagnosis markets.

Since its establishment in 2015, Airdoc has continuously invested in basic scientific research in the field of artificial intelligence, dedicating itself to the development of AI-based retinal auxiliary diagnosis and health risk assessment technologies. Its AI medical imaging products have consistently remained at the forefront of technological advancements in this sector. The company’s AI algorithm models incorporate convolutional neural networks with over 100 layers, achieving remarkable breakthroughs in key performance indicators such as sensitivity and specificity, and have received numerous industry honors and awards.

In August 2020, Airdoc’s AI-based auxiliary diagnostic software for diabetic retinopathy fundus images received approval from the National Medical Products Administration (NMPA), becoming one of the first AI products for diabetic retinopathy screening to obtain a Class III medical device certificate in China. This milestone marked a significant step forward in the application of artificial intelligence technology to auxiliary diagnosis based on retinal imaging in China.

Currently, Airdoc’s multiple products provide health risk assessment services and clinical decision support to tens of thousands of users daily. By significantly improving diagnostic efficiency in clinical settings, these solutions help alleviate the heavy burden of hospital consultations while empowering users to assess their health risks. In addition to achieving successful commercialization of “AI + Healthcare,” Airdoc continuously enhances the end-to-end user experience of its AI products, considering factors ranging from pricing to convenience, thereby expanding the accessibility of health management across China.

The Second Conference retained the theme “Health for All, Everywhere: The 2030 Era of Sustainable Development,” with the slogan “Health for All.” It continued to feature three major sub-themes—“Achieving Universal Health Coverage,” “Innovation for Health,” and “Health in All Policies”—and adopted a “1+2+33+15” format, comprising one opening ceremony, two plenary sessions, 33 parallel forums, and 15 key events.

On October 25, 2018, the 197 member states of the World Health Organization convened at the Global Conference on Primary Health Care and unanimously adopted the Astana Declaration, reaffirming that strengthening primary health care is a crucial step toward achieving universal health coverage. As the world’s most populous country and the largest developing nation, China has promulgated and implemented action plans such as the Outline of the “Healthy China 2030” Plan and the Guiding Opinions on Promoting the Development of “Internet + Healthcare.” In active alignment with the spirit of the Astana Declaration, to mobilize political will within the international community, seek the integration of public policy, business, and technological innovation, and establish a long-term platform for health cooperation and exchange among government, academia, business, civil society, media, and non-governmental organizations both domestically and internationally, all aimed at jointly advancing the realization of the United Nations’ 2030 Sustainable Development Goals, the Boao Forum for Asia (BFA), as a non-governmental, non-profit international organization, has decided to establish the Boao Forum for Asia Global Health Forum Conference, following extensive consultation with all relevant stakeholders.

From June 10 to 12, 2019, the inaugural Boao Forum for Asia Global Health Conference was successfully held. Representatives from enterprises and institutions across 55 countries and regions gathered in Qingdao, Shandong Province, China, to share insights and inspire wisdom on “health,” a topic of common concern to all humanity. Discussions centered on three major sub-themes: “Achieving Universal Health,” “Innovation for Health Promotion,” and “Health in All Policies.”

Global growth consulting firm Frost & Sullivan, referred to as “Sullivan,” integrates 60 years of global consulting experience to provide enterprises with comprehensive investment and financing services, including industry advisory, technical advisory, financial advisory, strategic consulting, management consulting, and planning consulting. Over the past 60 years, Sullivan has helped numerous clients worldwide achieve their strategic objectives, including Fortune Global 1000 companies, emerging enterprises, and investment institutions.

For 23 years, Sullivan China has been dedicated to serving the booming Chinese market. With a global perspective, we help clients accelerate their corporate growth and empower them to achieve benchmark positions in industry growth, scientific and technological innovation, and leadership. We are a leading enterprise in the field of investment strategy consulting in China.

As a key partner of the 2nd Global Health Forum of the Boao Forum for Asia, Sullivan will collaborate with the forum to integrate capital and industrial resources, committed to building a multi-tiered medical security system and promoting health management through health insurance.